Lazard Asset Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-863
Closed -$62K 2546
2025
Q1
$62K Sell
863
-92
-10% -$7.72K ﹤0.01% 1947
2024
Q4
$84K Buy
+955
New +$85.1K ﹤0.01% 1852
2022
Q2
Sell
-453
Closed -$45K 2585
2022
Q1
$45K Buy
453
+400
+755% +$38.1K ﹤0.01% 1799
2021
Q4
$5K Sell
53
-199
-79% -$19.9K ﹤0.01% 2172
2021
Q3
$27K Buy
+252
New +$28.7K ﹤0.01% 1936
2021
Q2
Sell
-437
Closed -$45K 2083
2021
Q1
$45K Sell
437
-12,050
-97% -$1.5M ﹤0.01% 1486
2020
Q4
$1.5M Buy
+12,487
New +$1.26M ﹤0.01% 841
2015
Q2
Sell
-21,729
Closed -$1.03M 1184
2015
Q1
$1.03M Buy
21,729
+21,713
+135,706% +$923K ﹤0.01% 702
2014
Q4
$0 Buy
+16
New +$630 ﹤0.01% 1169

Other funds holding USPH

Lazard Asset Management's USPH Position: Q2 2025 in Review

Lazard Asset Management sold out of US Physical Therapy (USPH) in Q2 2025, closing a stake of 863 shares — an estimated $62K sold.

Lazard Asset Management first reported a position in USPH in Q4 2014 and held it in 9 quarters. The position peaked at $1.5M in Q4 2020. 240 funds tracked by Wall St. Rank hold USPH as of Q2 2025.

  • Lazard Asset Management reported no remaining US Physical Therapy position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 863 US Physical Therapy shares in Q2 2025, an estimated $62K.
  • Lazard Asset Management first reported a position in US Physical Therapy in Q4 2014 and held it in 9 quarters.
  • Lazard Asset Management's US Physical Therapy position peaked at $1.5M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.